Why is Medicover AB ?
- The company is Net-Debt Free
- OPERATING CASH FLOW(Y) Highest at SEK 3,105.56 MM
- ROCE(HY) Highest at 16.58%
- INTEREST COVERAGE RATIO(Q) Highest at 645.18
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -14.18%, its profits have risen by 59% ; the PEG ratio of the company is 0.6
- Even though the market (OMX Stockholm 30) has generated returns of 26.99% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -14.18% returns
How much should you hold?
- Overall Portfolio exposure to Medicover AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Medicover AB for you?
Medium Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK 3,105.56 MM
Highest at 16.58%
Highest at 645.18
Fallen by -0.83% (YoY
Highest at 29.54 times
Highest at SEK 6,972.74 MM
Highest at SEK 1,166.12 MM
Highest at 16.72 %
Highest at SEK 364.75 MM
Highest at SEK 269.11 MM
Highest at SEK 1.76
Lowest at 6.92 times
Here's what is working for Medicover AB
Operating Cash Flows (SEK MM)
Operating Profit to Interest
Net Sales (SEK MM)
Operating Profit (SEK MM)
Operating Profit to Sales
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Medicover AB
Debtors Turnover Ratio






